I-Esomeprazole, umuthi onamandla, uguqule isimo ukwelashwa kwezinkinga zesisu. Lo muthi ophawulekayo usiza ekwelapheni izifo eziningi zesisu, njenge-gastroesophageal Reflux disease (GERD) kanye nezilonda zesisu. Masiqonde ukuthi i-esomeprazole isebenza kanjani emzimbeni wethu, ukusebenzisana kwayo neminye imithi, kanye nolwazi olufanele lomthamo.
I-Esomeprazole umuthi onamandla oyingxenye yemithi ebizwa ngokuthi i-proton pump inhibitors (PPIs) futhi unomthelela endleleni isisu esikhiqiza ngayo i-asidi. Isebenza kahle kakhulu ekuphatheni isifo se-reflux se-gastroesophageal (GERD), i-dyspepsia, isifo se-peptic ulcer, kanye nesimo esingavamile esibizwa ngokuthi i-Zollinger-Ellison syndrome.
I-Esomeprazole iphinde ibambe iqhaza ekuvimbeleni izilonda zesisu kubantu abavame ukusebenzisa izidakamizwa ezingezona ukuvuvukala (ama-NSAID).
I-Esomeprazole inezinhlobo eziningi zezicelo ekwelapheni ukuphazamiseka okuhlukahlukene kokugaya ukudla, okuhlanganisa:
Nawu umhlahlandlela ophelele wokuthi ungasebenzisa kanjani i-esomeprazole ngempumelelo:
Nakuba i-esomeprazole ngokuvamile ibekezelelwa kahle, kubalulekile ukuqaphela imiphumela engemihle engaba khona. Imiphumela emibi evamile ye-esomeprazole ihlanganisa:
Nakuba ingavamile, imiphumela emibi ye-esomeprazole ingenzeka kubantu abangaphansi ko-1 kwabayi-1,000, njengalokhu:
Ezimweni ezingavamile kakhulu, i-esomeprazole ingabangela ukungezwani okukhulu (anaphylaxis). Izimpawu zihlanganisa ukuvuvukala okungazelelwe kwezindebe, umlomo, umphimbo, noma ulimi; ubunzima bokuphefumula; isikhumba, ulimi, noma izindebe ezishintsha umbala; ukudideka; noma ukuquleka.
Lapho usebenzisa i-esomeprazole, kubalulekile ukuthatha izinyathelo ezithile zokuphepha ukuze uqinisekise ukwelashwa okuphephile nokusebenzayo, okuhlanganisa:
Iziguli kufanele ziqaphele izimpawu zemiphumela emibi kakhulu futhi zibikele udokotela wazo ngokushesha. Lokhu kubandakanya:
Indlela i-esomeprazole esebenza ngayo iyathakazelisa. Iqondise isinyathelo sokugcina sokukhiqizwa kwe-asidi esiswini esiswini. Ngokukhethekile, ibophezela ezingxenyeni ezithile ze-enzyme (H+, K+) -ATPase etholakala ebusweni bamaseli e-gastric parietal. Lokhu kubophezela akubuyiseleki emuva, okusho ukuthi uma i-esomeprazole isinamathela kwi-enzyme, ihlala injalo. Lesi sici esiyingqayizivele sinikeza i-esomeprazole umphumela we-antisecretory othatha amahora angaphezu kwama-24. Ngenxa yalokho, ivimbela kokubili ukukhishwa kwe-basal kanye ne-stimulated gastric acid. Kusho ukuthi kungakhathaliseki ukuthi yini ebangela ukukhiqizwa kwe-asidi - noma ngabe ukudla, ingcindezi, noma ezinye izici - i-esomeprazole isebenza ukuyinciphisa.
Nakuba isenzo esiyinhloko se-esomeprazole siwukunciphisa i-asidi esiswini, ucwaningo lwakamuva luveze omunye umphumela wama-PPI njenge-esomeprazole. Le mithi iphinde ivimbele i-enzyme ebizwa ngokuthi i-dimethylarginine dimethylaminohydrolase (DDAH). Le enzyme idlala indima empilweni yenhliziyo nemithambo yegazi. Uma i-DDAH ivinjiwe, into engaphazamisa ukukhiqizwa kwe-nitric oxide iyanqwabelana. Lokhu okutholakele kuye kwaholela ezingxoxweni mayelana nokuhlobana okungenzeka phakathi kokusetshenziswa kwesikhathi eside kwe-PPI kanye nengozi eyengeziwe yezinkinga zenhliziyo kwezinye iziguli.
I-Esomeprazole inomthelela emithini eyehlukene kanye nezithasiselo, okwenza kube semqoka ukwazisa odokotela ngazo zonke izindlela zokwelapha zamanje.
Eminye yemithi engase ihlanganyele ne-esomeprazole ihlanganisa:
Umthamo we-Esomeprazole uyahlukahluka kuye ngesimo sokwelashwa kanye neminyaka yesiguli. Odokotela banquma umthamo ofanele ngokusekelwe ezidingweni zomuntu ngamunye kanye nomlando wezokwelapha.
Kubantu abadala abanesifo se-reflux ye-gastroesophageal (GERD), umthamo ojwayelekile we-esomeprazole magnesium ngu-20 mg ngomlomo nsuku zonke.
Ezimweni ze-erosive esophagitis, abantu abadala ngokuvamile bathatha 20 kuya ku-40 mg we-esomeprazole magnesium ngomlomo kanye ngosuku amaviki angu-4 kuya kwangu-8 ukuze belaphe. Ukuze isondlo, umthamo ngokuvamile 20 mg kanye ngosuku.
Odokotela banquma i-esomeprazole magnesium njengengxenye yohlelo lokwelapha oluphindwe kathathu lokutheleleka nge-Helicobacter pylori. Abantu abadala bathatha ama-40 mg ngomlomo kanye ngosuku, kanye ne-amoxicillin ne-clarithromycin, izinsuku eziyishumi.
Ukuvimbela izilonda zesisu ezibangelwa i-NSAID, abantu abadala bangathatha u-20 kuya ku-40 mg we-esomeprazole magnesium noma u-24.65 kuya ku-49.3 mg we-esomeprazole strontium ngomlomo nsuku zonke kuze kube yizinyanga eziyisi-6.
Umthamo wezingane uyahlukahluka ngeminyaka nangesisindo. Ezinganeni ezine-GERD ezineminyaka engu-1 kuye kweyi-11 ubudala, i-esomeprazole magnesium imvamisa inqunywa ku-10 mg ngomlomo kanye ngosuku kuze kube amasonto ayisishiyagalombili. Intsha eneminyaka engu-12 kuya ku-17 ngokuvamile ithatha i-20 mg kanye ngosuku amasonto amane.
I-Esomeprazole ithinta kakhulu impilo yokugaya ukudla, inikeze impumuzo ezigidini ezihlushwa yizimo ezihlobene ne-asidi. Ikhono layo elinamandla lokunciphisa ukukhiqizwa kwe-asidi yesisu liyenza ithuluzi elibalulekile ekwelapheni i-GERD, izilonda, nezinye izinkinga zesisu. Umphumela wesikhathi eside womuthi kanye nezithako ezihlukahlukene zinikeza ukuguquguquka kwezinketho zokwelapha, ukuhlinzeka ngezidingo ezahlukene zesiguli.
Nakuba i-esomeprazole ngokuvamile ibekezelelwa kahle, kubalulekile ukuyisebenzisa ngaphansi kokuqondisa kodokotela. Ukuhlolwa njalo nokuxhumana okuvulekile nodokotela kubalulekile ukuze kuqinisekiswe ukusetshenziswa okuphephile nokusebenza ngempumelelo.
I-Esomeprazole isetshenziselwa ikakhulukazi ukwelapha izifo ezihlukahlukene ezihlobene nokukhiqizwa kwe-asidi yesisu ngokweqile. Odokotela banikeza le mithi yokubhekana nesifo se-reflux ye-gastroesophageal (GERD), i-erosive esophagitis, isifo se-peptic ulcer (PUD), kanye nesifo se-Zollinger-Ellison. Iphinde isebenze inhloso yokuvimbela. Odokotela bayinikeza ukuze kuncishiswe ingozi yezilonda zesisu kubantu abavame ukusebenzisa izidakamizwa ezingezona ukuvuvukala (ama-NSAID).
Ukuphepha kwe-esomeprazole ezinso kube yisihloko sengxoxo emibuthanweni yezokwelapha. Nakuba i-esomeprazole ngokuvamile ibhekwa njengephephile, ezinye izifundo ziphakamisa ukuxhumana okungaba khona phakathi kokusetshenziswa kwayo nezindaba ezihlobene nezinso.
Ucwaningo luveze ukuthi ama-proton pump inhibitors (PPIs) afana ne-esomeprazole angase anyuse ingozi yesifo sezinso esingamahlalakhona (CKD) kubantu abanomsebenzi wezinso ojwayelekile. Nokho, kubalulekile ukuqaphela ukuthi lokhu akusho ukuthi wonke umuntu osebenzisa ama-PPI uzothuthukisa i-CKD. Ingozi incane uma kuqhathaniswa.
Ukuthatha i-esomeprazole nsuku zonke akulungile ngokwemvelo, kodwa kuza nokucatshangelwa okuqondile. Kubantu abaningi, ukusetshenziswa kwe-esomeprazole ngokuvamile kuthathwa njengokuphephile futhi kusebenza ngempumelelo uma kuthathwa njengoba kuyalelwe. Kodwa-ke, ukusetshenziswa isikhathi eside kwe-esomeprazole, ikakhulukazi izikhathi ezingaphezu konyaka, kungase kuholele ekukhathazeni okuthile kwezempilo, njengengozi eyengeziwe yokuphuka kwamathambo, ukuntuleka kwevithamini B12, amazinga aphansi e-magnesium, noma ama-polyps e-fundic gland. Iziguli kufanele zilandele imiyalelo kadokotela wazo ngokucophelela futhi zingawuphuzi umuthi isikhathi eside kunalokho okusikiselwe.
I-Esomeprazole ifakazele ukuthi iyi-ejenti yokwelapha ephumelelayo yokuthuthukisa izimpawu ze-GERD. Izivivinyo zemitholampilo nokuhlaziywa kwe-meta kubonise ukuthi i-esomeprazole inikeza amazinga aphezulu okuphulukiswa kwe-GERD egugulekayo kunamanye ama-proton pump inhibitors.